OCS-05 was well tolerated and improved vision and eye health in a Phase 2 trial in 33 people with optic neuritis due to MS or ...

Scientists say IRX4204 given to mice with evident symptoms showed potential "as a remyelinating and neurorestorative ...

Columnist Ahna Crum is taking on a new year with a different approach: meeting the day-to-day new beginnings in life with ...

Certain health issues seen in youth with MS in the five years before diagnosis confirm a prodromal period may exist in ...

Men with MS who started on high-efficacy DMTs had fewer relapses than those who started with moderate-efficacy DMTs, a U.S.

Columnist Ben Hofmeister offers a tongue-in-cheek collective nouns list for multiple sclerosis, its symptoms, and other things.

Long-term Tecfidera use was found to significantly reduce relapse rates and slow disability progression for MS patients in a ...

Most MS treatments don't increase the risk for miscarriage or major birth defects when used during pregnancy, an analysis ...

Columnist Ben Hofmeister is learning that navigating life with multiple sclerosis is a journey, rather than a quest or an adventure.

The most-read stories published by Multiple Sclerosis News Today in 2024 focused on living with MS and news on disease risk factors.